Jay Cusack

Jay Cusack currently serves as the Global Commercial Lead for Zasocitinib in Dermatology and Immunology at Takeda, where responsibilities include shaping and executing the global launch strategy for Zasocitinib in psoriasis. Prior experience at AbbVie includes roles such as Senior Director of Strategic Marketing for U.S. Immunology, where a successful launch of RINVOQ in atopic dermatitis was achieved, and Commercial Director for Immunology across Eastern Europe, the Middle East, and Africa, responsible for delivering over $500MM in HUMIRA sales and launching SKYRIZI and RINVOQ. Earlier positions at AbbVie and Abbott involved leading various marketing and sales initiatives, including launching HUMIRA formulations and managing the Rheumatology Business Unit. Jay Cusack began a career in the pharmaceutical industry at Pfizer, holding multiple roles in sales and marketing. Educational qualifications include a Bachelor of Business and a Bachelor of Applied Science in Marketing and Sports Science from Queensland University of Technology.